HDAC INHIBITOR-TARGETED THERAPY WITH NANOMEDICINE INCREASES THE EFFICACY OF PACLITAXEL IN TRIPLE NEGATIVE BREAST CANCER

Master's

Saved in:

Bibliographic Details
Main Author:	LIM CHEN SIEW
Other Authors:	CHEMICAL & BIOMOLECULAR ENGINEERING
Format:	Theses and Dissertations
Language:	English
Published:	2014
Subjects:	nanomedicine, cancer, epigenetics, vorinostat, paclitaxel, breast
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/79259
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-79259
record_format	dspace
spelling	sg-nus-scholar.10635-792592015-01-07T13:00:45Z HDAC INHIBITOR-TARGETED THERAPY WITH NANOMEDICINE INCREASES THE EFFICACY OF PACLITAXEL IN TRIPLE NEGATIVE BREAST CANCER LIM CHEN SIEW CHEMICAL & BIOMOLECULAR ENGINEERING LEONG TAI WEI DAVID FENG SI-SHEN nanomedicine, cancer, epigenetics, vorinostat, paclitaxel, breast Master's MASTER OF ENGINEERING 2014-08-07T18:00:12Z 2014-08-07T18:00:12Z 2014-01-24 Thesis LIM CHEN SIEW (2014-01-24). HDAC INHIBITOR-TARGETED THERAPY WITH NANOMEDICINE INCREASES THE EFFICACY OF PACLITAXEL IN TRIPLE NEGATIVE BREAST CANCER. ScholarBank@NUS Repository. http://scholarbank.nus.edu.sg/handle/10635/79259 NOT_IN_WOS en
institution	National University of Singapore
building	NUS Library
country	Singapore
collection	ScholarBank@NUS
language	English
topic	nanomedicine, cancer, epigenetics, vorinostat, paclitaxel, breast
spellingShingle	nanomedicine, cancer, epigenetics, vorinostat, paclitaxel, breast LIM CHEN SIEW HDAC INHIBITOR-TARGETED THERAPY WITH NANOMEDICINE INCREASES THE EFFICACY OF PACLITAXEL IN TRIPLE NEGATIVE BREAST CANCER
description	Master's
author2	CHEMICAL & BIOMOLECULAR ENGINEERING
author_facet	CHEMICAL & BIOMOLECULAR ENGINEERING LIM CHEN SIEW
format	Theses and Dissertations
author	LIM CHEN SIEW
author_sort	LIM CHEN SIEW
title	HDAC INHIBITOR-TARGETED THERAPY WITH NANOMEDICINE INCREASES THE EFFICACY OF PACLITAXEL IN TRIPLE NEGATIVE BREAST CANCER
title_short	HDAC INHIBITOR-TARGETED THERAPY WITH NANOMEDICINE INCREASES THE EFFICACY OF PACLITAXEL IN TRIPLE NEGATIVE BREAST CANCER
title_full	HDAC INHIBITOR-TARGETED THERAPY WITH NANOMEDICINE INCREASES THE EFFICACY OF PACLITAXEL IN TRIPLE NEGATIVE BREAST CANCER
title_fullStr	HDAC INHIBITOR-TARGETED THERAPY WITH NANOMEDICINE INCREASES THE EFFICACY OF PACLITAXEL IN TRIPLE NEGATIVE BREAST CANCER
title_full_unstemmed	HDAC INHIBITOR-TARGETED THERAPY WITH NANOMEDICINE INCREASES THE EFFICACY OF PACLITAXEL IN TRIPLE NEGATIVE BREAST CANCER
title_sort	hdac inhibitor-targeted therapy with nanomedicine increases the efficacy of paclitaxel in triple negative breast cancer
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/79259
_version_	1681088804980523008

HDAC INHIBITOR-TARGETED THERAPY WITH NANOMEDICINE INCREASES THE EFFICACY OF PACLITAXEL IN TRIPLE NEGATIVE BREAST CANCER

Similar Items